Every Indian IPO in one place. We score each one, and show how often we were right.
GMP is an informal figure from outside SEBI's framework. Not investment advice.
Pramodini Medicare is an SME issue priced at ₹118 a share. One lot is 1,200 shares, which costs ₹1,41,600. The book is 1.08 times subscribed overall. Our call is Risky, on 78% of our checks.
1 further check could not be judged, because the issue did not disclose enough. They count neither for nor against.